2B70.DE vs. SHY

Last updated Apr 2, 2026

Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares 1-3 Year Treasury Bond ETF (SHY).

2B70.DE and SHY are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. SHY is a passively managed fund by iShares that tracks the performance of the Barclays Capital U.S. 1-3 Year Treasury Bond Index. It was launched on Jul 22, 2002. Both 2B70.DE and SHY are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.

Performance

2B70.DE vs. SHY - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares 1-3 Year Treasury Bond ETF (SHY). The values are adjusted to include any dividend payments, if applicable.

2B70.DE vs. SHY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF	3.64%	18.62%	4.60%	2.56%	-6.29%	7.59%	14.52%	30.18%	-7.35%	2.65%
SHY iShares 1-3 Year Treasury Bond ETF	1.81%	-7.50%	10.78%	1.04%	2.08%	6.71%	-5.46%	5.72%	6.23%	-1.59%

Different Trading Currencies

2B70.DE is traded in EUR, while SHY is traded in USD. To make them comparable, the SHY values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, 2B70.DE achieves a 3.64% return, which is significantly higher than SHY's 1.81% return.

2B70.DE

• 1D: 1.60%
• 1M: -0.58%
• YTD: 3.64%
• 6M: 18.58%
• 1Y: 29.69%
• 3Y*: 10.78%
• 5Y*: 4.95%
• 10Y*: —

SHY

• 1D: -0.11%
• 1M: 0.76%
• YTD: 1.81%
• 6M: 2.66%
• 1Y: -3.36%
• 3Y*: 1.66%
• 5Y*: 2.07%
• 10Y*: 1.50%

*Multi-year figures are annualized to reflect compound growth (CAGR)

2B70.DE vs. SHY - Expense Ratio Comparison

2B70.DE has a 0.35% expense ratio, which is higher than SHY's 0.15% expense ratio.

2B70.DE

iShares Nasdaq US Biotechnology UCITS ETF

SHY

iShares 1-3 Year Treasury Bond ETF

Return for Risk

2B70.DE vs. SHY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2B70.DE

2B70.DE Risk / Return Rank: 74
2B70.DE Sharpe Ratio Rank: 71
2B70.DE Sortino Ratio Rank: 70
2B70.DE Omega Ratio Rank: 63
2B70.DE Calmar Ratio Rank: 82
2B70.DE Martin Ratio Rank: 86

SHY

SHY Risk / Return Rank: 96
SHY Sharpe Ratio Rank: 95
SHY Sortino Ratio Rank: 98
SHY Omega Ratio Rank: 96
SHY Calmar Ratio Rank: 95
SHY Martin Ratio Rank: 95

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2B70.DE vs. SHY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and iShares 1-3 Year Treasury Bond ETF (SHY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	2B70.DE	SHY	Difference
Sharpe ratio Return per unit of total volatility	1.31	-0.46	+1.77
Sortino ratio Return per unit of downside risk	1.83	-0.56	+2.38
Omega ratio Gain probability vs. loss probability	1.24	0.93	+0.31
Calmar ratio Return relative to maximum drawdown	2.49	-0.41	+2.90
Martin ratio Return relative to average drawdown	10.78	-0.61	+11.39
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2B70.DE vs. SHY - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 1.31, which is higher than the SHY Sharpe Ratio of -0.46. The chart below compares the historical Sharpe Ratios of 2B70.DE and SHY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	2B70.DE	SHY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.31	-0.46	+1.77
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.24	0.28	-0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.21	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.36	0.29	+0.07

Correlation

The correlation between 2B70.DE and SHY is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

2B70.DE vs. SHY - Dividend Comparison

2B70.DE has not paid dividends to shareholders, while SHY's dividend yield for the trailing twelve months is around 3.72%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SHY iShares 1-3 Year Treasury Bond ETF	3.72%	3.81%	3.92%	2.99%	1.30%	0.26%	0.94%	2.12%	1.72%	0.98%	0.71%	0.54%

Drawdowns

2B70.DE vs. SHY - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, which is greater than SHY's maximum drawdown of -18.74%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and SHY.

Drawdown Indicators

	2B70.DE	SHY	Difference
Max Drawdown Largest peak-to-trough decline	-30.87%	-5.71%	-25.16%
Max Drawdown (1Y) Largest decline over 1 year	-15.56%	-0.89%	-14.67%
Max Drawdown (5Y) Largest decline over 5 years	-30.87%	-5.71%	-25.16%
Max Drawdown (10Y) Largest decline over 10 years	—	-5.71%	—
Current Drawdown Current decline from peak	-1.07%	-0.47%	-0.60%
Average Drawdown Average peak-to-trough decline	-10.17%	-0.52%	-9.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.93%	0.23%	+2.70%

Volatility

2B70.DE vs. SHY - Volatility Comparison

iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.80% compared to iShares 1-3 Year Treasury Bond ETF (SHY) at 2.00%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than SHY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	2B70.DE	SHY	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.80%	2.00%	+4.80%
Volatility (6M) Calculated over the trailing 6-month period	14.03%	4.18%	+9.85%
Volatility (1Y) Calculated over the trailing 1-year period	22.48%	7.41%	+15.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.46%	7.32%	+13.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.78%	7.21%	+14.57%